Skip to main content

CDC: Little Change in Risky Teen Sex


July 27, 2012 — Progress in getting teens to have safer sex largely has stalled over the last decade, a new CDC study suggests.
Nearly half of high school students (47%) have had sex, according to the 2011 Youth Risk Behavior Survey (YRBS). That's almost the same percentage reported in the 2001 survey -- 46%.
That means the decline in sexually active teens seen in the 1990s -- from a 1991 high of 54% -- is now stalled. So are other markers of safer sex (or abstinence) among teens:
  • 34% of high school students had sex in the preceding three months. There's been little decline since the 1990s saw a slight decline from 38% in 1991.
  • 15% of high school students had four or more sex partners, stable since 14% in 1991 but not as high as the 19% seen in 1991.
  • 60% of high school students used a condom the last time they had sex.
"We have to step back and think about the lack of urgency about the HIV/AIDS epidemic in the U.S.," Kevin Fenton, MD, director of the CDC's AIDS center, said at the International AIDS Conference. "Fewer Americans say HIV is a health concern. This influences the vigor and commitment that schools and communities have in providing sexual health information to children. ... We have to generate a new sense of urgency. Part of that will be getting back on track reducing HIV behavior in young people."
One bright point in the study findings is that the sexual risk behaviors of African-American teens are dropping to levels similar to those of white and Hispanic teens. In fact, African-American teens are even more likely than other teens to use condoms.
But rates of sexual initiation, multiple lifetime sex partners, and recent sex remain higher among African-American teens.
"Age at first intercourse has not changed since we have been tracking it," study leader Laura Kann, PhD, said at the AIDS conference. "It still is usually about age 16 for boys and for girls."
The YRBS survey includes a large national sample of high school students, who answer very personal questions anonymously and in private. Pregnancy and STD data suggest that kids tend to tell the truth on YRBS questionnaires.
SOURCES:
News conference at International AIDS Conference, July 24, 2011.

Comments

Post a Comment

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...
Post a Comment
Read more

FDA Approvals: Pazopanib for Advanced Soft Tissue Sarcoma

CLINICAL CONTEXT Pazopanib was first approved by the US Food and Drug Administration (FDA) in 2009 when it became the sixth drug approved to treat advanced renal cell carcinoma. It is a small molecule with a mechanism of action as a tyrosine kinase inhibitor, specifically targeting receptors involved in angiogenesis and tumor cell proliferation. These include vascular endothelial growth-factor receptors 1, 2, and 3; platelet-derived growth-factor receptors α and β; fibroblast growth-factor receptors 1 and 3; stem cell factor receptors; interleukin-2-inducible T-cell kinase; leukocyte-specific protein tyrosine kinase; and transmembrane glycoprotein-receptor tyrosine kinase. STUDY SYNOPSIS AND PERSPECTIVE The FDA has approved pazopanib ( Votrient ) for the treatment of advanced soft tissue sarcoma in patients who have received previous chemotherapy. Pazopanib is already marketed for the treatment of advanced renal cell carcinoma; when it was approved in 2009, it became the six...
Post a Comment
Read more

CareFusion Issues Update on Infant Breathing Product Recall

July 5, 2012 — Medical device maker CareFusion has issued an update reminding healthcare providers of its voluntary recall of its Air Life ™ Infant Breathing Circuit, initiated back in May. The US Food and Drug Administration (FDA) has classified this action as a class 1 recall, meaning there is a reasonable probability of serious adverse health consequences or death associated with use of the defective units. The update was posted July 2 on the FDA  Website. On May 29, 2012, CareFusion sent an  Urgent Recall Notice  to customers and distributors stating that the company had identified potential risks associated with the Air Life  Infant Breathing Circuit. The action was initiated after the company received complaints of the Y adapter within the breathing circuit developing cracks during patient use. "If a crack develops in the Y adapter, this could potentially result in a leak in the closed ventilation system, leading to a loss in the intended tidal volum...
Post a Comment
Read more